Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death

被引:212
作者
Acharya, Subrat Kumar [1 ]
Sharma, Praveen Kumar
Singh, Rajbir
Mohanty, Sujit Kumar
Madan, Kaushal
Jha, Jyotish Kumar
Panda, Subrat Kumar
机构
[1] All India Inst Med Sci, Dept Gastroenterol, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India
[3] All India Inst Med Sci, Dept Biostat, New Delhi 110029, India
关键词
HEV; cirrhosis; decompensation; death;
D O I
10.1016/j.jhep.2006.09.016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: India is hyper-endemic for hepatitis E virus (HEV). HEV infection in cirrhosis may cause high mortality. Prospective study evaluating HEV infection in cirrhotics is scarce. Methods: Consecutive patients with cirrhosis and healthy controls were included. Cirrhotics were categorized to 3 groups, (Group I - rapid decompensation, Group II - chronically decompensated, Group III - cirrhotics without decompensation). Sera from cirrhotics and controls were tested for HEV-RNA (RT-PCR). HEV-RNA positivity among cirrhotics and controls was compared. Natural course and mortality rate between HEV infected and non-infected cirrhotics were assessed during a 12-month follow-up. Results: 107 cirrhotics and 200 controls were included. 30 (28%) cirrhotics and 9 (4.5%) controls had detectable HEV-RNA (p < 0.001). HEV- RNA positivity among Group I (n = 42), II (n = 32) and III (n = 33) cirrhotics was 21 (50%), 6 (19%) and 3 (10%), respectively (p = 0.002). 70% (21/30) with HEV infection and 27% (21/77) without it had rapid decompensation (p = 0.001). Mortality between HEV infected and non-infected cirrhotics at 4 weeks (43% vs. 22%, p = 0.001) and 12 month (70% vs. 30%, p = 0.001) was different. Multivariate analysis identified HEV infection, Child-Pugh's score, renal failure, and sepsis as independent factors for mortality. Conclusions: In India, cirrhotics were prone to HEV infection, which was associated with rapid decompensation and death. (c) 2006 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:387 / 394
页数:8
相关论文
共 43 条
[1]   ENZYMATIC GENE AMPLIFICATION - QUALITATIVE AND QUANTITATIVE METHODS FOR DETECTING PROVIRAL DNA AMPLIFIED INVITRO [J].
ABBOTT, MA ;
POIESZ, BJ ;
BYRNE, BC ;
KWOK, S ;
SNINSKY, JJ ;
EHRLICH, GD .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) :1158-1169
[2]  
ABE A, 1989, CLIN CHEM, V35, P552
[3]   Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: Implications for HAV vaccination [J].
Acharya, SK ;
Batra, Y ;
Bhatkal, B ;
Ojha, B ;
Kaur, K ;
Hazari, S ;
Saraya, A ;
Panda, SK .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (07) :822-827
[4]  
Acharya SK, 2002, NATL MED J INDIA, V15, P267
[5]   Hepatitis E: Is it a blood-borne pathogen? [J].
Aggarwal, R .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (07) :729-731
[6]   Hepatitis E: An overview and recent advances in clinical and laboratory research [J].
Aggarwal, R ;
Krawczynski, K .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (01) :9-20
[7]  
[Anonymous], 1996, MMWR Recomm Rep, V45, P1
[8]   Hepatitis E virus: can it be transmitted parenterally? [J].
Arankalle, VA ;
Chobe, LP .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 (02) :161-164
[9]  
Batra Y, 2002, B WORLD HEALTH ORGAN, V80, P728
[10]  
Bylund DJ, 1997, CLIN LAB MED, V17, P483